William Blair Predicts Veracyte’s Q2 Earnings (NASDAQ:VCYT)
Veracyte, Inc. (NASDAQ:VCYT – Free Report) – Investment analysts at William Blair boosted their Q2 2025 earnings estimates for shares of Veracyte in a research note issued to investors on Tuesday, May 13th. William Blair analyst A. Brackmann now anticipates that the biotechnology company will post earnings per share of $0.19 for the quarter, up […]
